Reuters logo
22 天前
BRIEF-Prothena to initiate mid-stage trial of its Parkinson's drug
2017年7月5日 / 晚上8点22分 / 22 天前

BRIEF-Prothena to initiate mid-stage trial of its Parkinson's drug

1 分钟阅读

July 5 (Reuters) - Prothena Corporation Plc-

* Prothena announces initiation of phase 2 PASADENA study of prx002/rg7935 in patients with early Parkinson's disease

* Prothena Corporation Plc says to receive $30 million milestone payment under collaboration agreement with Roche Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below